168 related articles for article (PubMed ID: 6205772)
1. Monoclonal antibody-defined surface markers of effector cells involved in human monocyte cytotoxicity.
Villa A; Peri G; Rossi V; Delia D; Mantovani A
Cell Immunol; 1984 Sep; 87(2):494-503. PubMed ID: 6205772
[TBL] [Abstract][Full Text] [Related]
2. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
3. Characterization by monoclonal antibodies of the cytotoxic effector cells in human peripheral blood mononuclear cells reactive against anchorage-dependent tumour cell lines.
Chang ZL; Hoffman T; Stevenson HC; Trinchieri G; Herberman RB
Scand J Immunol; 1983 Nov; 18(5):451-9. PubMed ID: 6648368
[TBL] [Abstract][Full Text] [Related]
4. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
Frey JR; Kamber M; Peck R
Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
[TBL] [Abstract][Full Text] [Related]
5. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D.
Uchida A; Klein E
Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288
[TBL] [Abstract][Full Text] [Related]
6. The cytotoxic effector cells in preparations of adherent mononuclear cells from human peripheral blood.
Freundlich B; Trinchieri G; Perussia B; Zurier RB
J Immunol; 1984 Mar; 132(3):1255-60. PubMed ID: 6693767
[TBL] [Abstract][Full Text] [Related]
7. Monocyte and NK cell cytotoxic activity in human adherent cell preparations: discriminating effects of interferon and lactoferrin.
Horwitz DA; Bakke AC; Abo W; Nishiya K
J Immunol; 1984 May; 132(5):2370-4. PubMed ID: 6201542
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous cytotoxicity by monocyte-enriched subpopulations of human peripheral blood mononuclear cells against human or mouse anchorage-dependent tumour cell lines. Contribution of NK-like cells.
Chang ZL; Hoffman T; Bonvini E; Stevenson HC; Herberman RB
Scand J Immunol; 1983 Nov; 18(5):439-49. PubMed ID: 6648367
[TBL] [Abstract][Full Text] [Related]
9. Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons.
Sztein MB; Steeg PS; Johnson HM; Oppenheim JJ
J Clin Invest; 1984 Feb; 73(2):556-65. PubMed ID: 6230374
[TBL] [Abstract][Full Text] [Related]
10. Rapidly expanded activated human killer cell clones have strong antitumor cell activity and have the surface phenotype of either T gamma, T-non-gamma, or null cells.
van de Griend RJ; van Krimpen BA; Ronteltap CP; Bolhuis RL
J Immunol; 1984 Jun; 132(6):3185-91. PubMed ID: 6233369
[TBL] [Abstract][Full Text] [Related]
11. Natural cytotoxicity of human blood lymphocytes and monocytes and their cytotoxic factors: effect of interferon on target cell susceptibility.
Uchida A; Vánky F; Klein E
J Natl Cancer Inst; 1985 Nov; 75(5):849-57. PubMed ID: 2414505
[TBL] [Abstract][Full Text] [Related]
12. Antibody-dependent and -independent cytotoxicity of human mononuclear phagocytes: defective stimulation of tumoricidal activity in milk macrophages.
Biondi A; Peri G; Colombo N; Bolis G; Mantovani A
Clin Exp Immunol; 1982 Sep; 49(3):701-8. PubMed ID: 7172502
[TBL] [Abstract][Full Text] [Related]
13. Monocyte- and natural killer cell-mediated spontaneous cytotoxicity against human noncultured solid tumor cells.
Itoh K; Platsoucas CD; Balch CM
Cell Immunol; 1987 Sep; 108(2):495-500. PubMed ID: 3113744
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity to tumor cells of monocytes from normal individuals and cancer patients.
Gerrard TL; Terz JJ; Kaplan AM
Int J Cancer; 1980 Nov; 26(5):585-93. PubMed ID: 7239718
[TBL] [Abstract][Full Text] [Related]
15. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
Grimm EA; Mazumder A; Zhang HZ; Rosenberg SA
J Exp Med; 1982 Jun; 155(6):1823-41. PubMed ID: 6176669
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity on tumour cells of human mononuclear phagocytes: defective tumoricidal capacity of alveolar macrophages.
Bordignon C; Avallone R; Peri G; Polentarutti N; Mangioni C; Mantovani A
Clin Exp Immunol; 1980 Aug; 41(2):336-42. PubMed ID: 6160006
[TBL] [Abstract][Full Text] [Related]
17. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
[TBL] [Abstract][Full Text] [Related]
18. The role of monocyte cytotoxic factor (CF) in cytostasis mediated by IFN-gamma-activated monocytes.
Kildahl-Andersen O; Nissen-Meyer J
Immunology; 1985 Oct; 56(2):367-72. PubMed ID: 3932193
[TBL] [Abstract][Full Text] [Related]
19. Role of endotoxin in the expression of human monocyte cytotoxicity.
Biondi A; Peri G; Lorenzet R; Fumarola D; Mantovani A
J Reticuloendothel Soc; 1983 Apr; 33(4):315-27. PubMed ID: 6187919
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity of temporarily adherent human mononuclear blood cells in monocyte monolayers.
Eggen BM
Int Arch Allergy Appl Immunol; 1983; 72(2):143-9. PubMed ID: 6192097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
